Cancer drug trial halted early: what happened?

NCT ID NCT05394675

First seen Jan 03, 2026 · Last updated Apr 24, 2026 · Updated 18 times

Summary

This early-stage study tested a new drug, DS-9606a, in 88 adults with advanced solid tumors that have a specific protein called Claudin-6. The main goal was to check safety and find the right dose. The trial was stopped early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Barbara Ann Karmanos Cancer Institute

    Detroit, Michigan, 48201, United States

  • Florida Cancer Specialists & Research Institute, LLC

    Fort Myers, Florida, 33916, United States

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • SCRI Oncology Partners

    Nashville, Tennessee, 37203, United States

  • SCRI at HealthONE

    Denver, Colorado, 80216, United States

  • Sarah Cannon Research Institute UK

    London, W1G 6AD, United Kingdom

  • The Royal Marsden NHS Trust

    Sutton, SM2 5PT, United Kingdom

Conditions

Explore the condition pages connected to this study.